Pancreatic Cancer Research

ResearcherUniversity of Electronic Science and Technology of ChinaActive in the last 2 years

Xiaolun Huang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4993-0802; OpenAlex author ID A5103113775. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
5
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 3

  1. Dendritic cell-related gene signature in pancreatic cancer stratifies patient subtypes and implicates a KCTD14-TNF signaling axis. Last author DOI 10.3389/fimmu.2025.1665906↗
  2. Intraoperative electron beam radiotherapy combined with gemcitabine and PD-L1 inhibitors for unresectable pancreatic cancer: Report of 3 cases. Last author DOI 10.1016/j.asjsur.2024.10.050↗
  3. Neoadjuvant Gemcitabine Chemotherapy followed by Concurrent IMRT Simultaneous Boost Achieves High R0 Resection in Borderline Resectable Pancreatic Cancer Patie… Co-author DOI 10.1371/journal.pone.0166606↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuxin Liang · 2 shared papers, 2024–2025 · strength 0.56
  2. Deyuan Zhong · 2 shared papers, 2024–2025 · strength 0.56
  3. Zilong Zhang · 1 shared paper, 2025 · strength 0.25
  4. Yahui Chen · 1 shared paper, 2025 · strength 0.25
  5. Hao Liu · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.